Utah Medical Products Inc (UTMD)
EBITDA Growth
-16.87%
TTM · Period ending:
UTMD EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-16.87%period ending
Latest reported-16.87%period ending
UTMD TTM EBITDA YoY % (185.71% → -16.87%)
Year-over-year change
High-resolution chart · PNG
UTMD ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| 1.7955% | |
| 1.9863% | |
| 0.7924% | |
| 4.902% | |
| 10.2551% | |
| 14.2258% | |
| 17.6854% | |
| 22.8916% | |
| 20.9877% | |
| 24% | |
| 27.1429% | |
| 0% | |
| -16.4948% | |
| -36.4407% | |
| -48.1481% | |
| -39.8551% | |
| -28.6765% | |
| -11.9403% | |
| 1.5038% | |
| 9.5238% | |
| 12.3967% | |
| 15.5172% | |
| 17.6991% | |
| 23.5294% | |
| 21% | |
| 14.8515% | |
| 14.1414% | |
| -4.6729% | |
| -9.9099% | |
| -4.717% | |
| -3.8835% | |
| 4.902% | |
| 16.8421% | |
| 17.7778% | |
| 21.1765% | |
| 29.1139% | |
| 28.3784% | |
| 25% | |
| 26.8657% | |
| 23.4375% | |
| 27.5862% | |
| 46.9388% | |
| -10.6667% | |
| 681.8182% | |
| 427.2727% | |
| 48.4848% | |
| 275% | |
| -125% | |
| -60.7143% | |
| 120% | |
| 185.7143% |